Trends in Antimicrobial Drug Use in the Community—France, 1981–1992

Trends in the use of antimicrobials in France between 1980–1981 and 1991–1992 were analyzed. Data were obtained from surveys of health and ambulatory care, which were based on national probability samples. In a 3-month period in 1980, 17% of the population of France was treated with an antibiotic, c...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1998-02, Vol.177 (2), p.492-497
Main Authors: Guillemot, Didier, Maison, Patrick, Carbon, Claude, Balkau, Beverley, Vauzelle-Kervroëdan, Françoise, Sermet, Catherine, Bouvenot, Gilles, Eschwège, Eveline
Format: Article
Language:English
Subjects:
Adult
Adults
Anti-Bacterial Agents - therapeutic use
Anti-Infective Agents - therapeutic use
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimicrobials
Biological and medical sciences
Cephalosporins
Cephalosporins - therapeutic use
Child
Concise Communications
Data Collection
Drug Utilization - trends
Etiology
Fluoroquinolones
France
General aspects
Humans
Infection - drug therapy
Infections
Medical sciences
Otitis media
Pharmacology. Drug treatments
Pharyngitis
Respiratory tract infections
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - virology
Virus Diseases - drug therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Trends in the use of antimicrobials in France between 1980–1981 and 1991–1992 were analyzed. Data were obtained from surveys of health and ambulatory care, which were based on national probability samples. In a 3-month period in 1980, 17% of the population of France was treated with an antibiotic, compared with 25% in 1991 (P < .001). The frequency of respiratory tract infections with a presumed viral etiology that were diagnosed and treated with antibiotics increased by 86% for adults and 115% for children in the 11-year period. The proper use of cephalosporins must be encouraged, and vigilance is required in view of the increased improper use of fluoroquinolones, mainly for respiratory tract infections with a presumed viral etiology.
ISSN:0022-1899
1537-6613
DOI:10.1086/517384